Published in Vaccine Weekly, December 29th, 2010
"The target protein was the major immunogenic domain of either the F (40 center dot 17-kDa) or G (11 center dot 49-kDa) glycoprotein domains of the RSV. Whole-cell ELISA readings obtained after 24 h of induction showed an increase in protein...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly